Federal Trade Commission v. Mylan Laboratories, Inc.

**Federal Trade Commission v. Mylan Laboratories: $110 Million Antitrust Settlement** This case involved allegations that Mylan Laboratories, a major pharmaceutical company, engaged in anticompetitive business practices that violated antitrust laws. The Federal Trade Commission brought the lawsuit as part of a larger legal action claiming Mylan manipulated markets in ways that harmed consumers and violated fair competition rules. The court approved a settlement agreement where Mylan agreed to pay $108 million total - $100 million to compensate consumers and state agencies, plus $8 million for legal costs and fees. Another company, SST, also paid $2 million as part of the settlement. Additional settlements were approved from other third-party companies involved in the case. **What This Means for Workers:** While this case primarily focused on antitrust violations rather than direct employment issues, it demonstrates how large corporations can face significant financial penalties when they break competition laws. For workers, this type of enforcement action can be important because anticompetitive practices often harm both consumers and employees by creating unfair market conditions. The substantial settlement also shows that government agencies actively pursue cases against major companies when they violate federal laws, which can provide some reassurance that corporate misconduct doesn't go unnoticed.